Loading clinical trials...
Loading clinical trials...
Intradiscal and Intra-articular Injection of Autologous Platelet-Rich-Plasma (PRP) in Patients With Lumbar Degenerative Disc Disease and Facet Joint Syndrome: A Prospective, Single-arm, Open Label Clinical Trial
Conditions
Interventions
Autologous PRP
Start Date
April 1, 2022
Primary Completion Date
October 1, 2024
Completion Date
October 1, 2024
Last Updated
March 23, 2022
NCT07127380
NCT07254806
NCT05508360
NCT05037968
NCT05029726
NCT06011551
Lead Sponsor
Stylianos Kapetanakis
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions